Inflammation is linked to the development of psychiatric illness. Recently, data has emerged on the usefulness of treating ...

Supernus Pharmaceuticals has linked its mTORC1 activator to rapid improvements in adults with major depressive disorder in a ...

SNRIs are often preferred for treating more severe cases of depression. Common examples include duloxetine, desvenlafaxine ...

Supernus Pharmaceuticals has said its candidate SPN-820, demonstrated a “rapid and substantial” effect in a Phase IIa trial ...

Recently, ketamine has become a fairly popular chemical compound. It has transitioned quickly from a party drug to a ...

Boston-based Seaport said the money would support a pipeline of improved neuropsychiatric drug candidates led by SPT-300, an ...

As Wes Streeting suggests new weight-loss jabs could be given to unemployed people to help them get back into work, doctors ...

The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...

The drugmaker plans to prioritize the launch of its postpartum depression pill Zurzuvae, that has been jointly developed with ...